Spectrumdna Stock Analysis

SpectrumDNA Stock Analysis Notes

The company recorded a loss per share of 0.04. SpectrumDNA had not issued any dividends in recent years. Spectrum DNA, Inc. operates a social media studio that creates digital networked applications, which are engines of engagement primarily for media outlets and brand advertisers. The company was founded in 2006 and is based in Park City, Utah. Spectrumdna operates under Internet Information Providers classification in the United States and is traded on OTC Exchange. It employs 8 people. To find out more about SpectrumDNA contact Parrish Ketchmark at 435 658 1349.

SpectrumDNA Investment Alerts

SpectrumDNA Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 684.98 K.

SpectrumDNA Profitablity

Management Efficiency

SpectrumDNA has return on total asset (ROA) of (3.917) % which means that it has lost $3.917 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.0267) %, meaning that it created substantial loss on money invested by shareholders. SpectrumDNA's management efficiency ratios could be used to measure how well SpectrumDNA manages its routine affairs as well as how well it operates its assets and liabilities. As of January 27, 2026, Return On Tangible Assets is expected to decline to -4.45. The current year's Return On Capital Employed is expected to grow to -5.48. At present, SpectrumDNA's Total Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 583.7 K, whereas Other Assets are forecasted to decline to about 117 K.

Technical Drivers

In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SpectrumDNA, as well as the relationship between them.

SpectrumDNA Price Movement Analysis

SpectrumDNA Financial Rating

SpectrumDNA financial ratings play a critical role in determining how much SpectrumDNA have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for SpectrumDNA's borrowing costs.

SpectrumDNA Debt to Cash Allocation

SpectrumDNA currently holds 15.83 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. SpectrumDNA has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about SpectrumDNA's use of debt, we should always consider it together with its cash and equity.

SpectrumDNA Total Assets Over Time

SpectrumDNA Assets Financed by Debt

The debt-to-assets ratio shows the degree to which SpectrumDNA uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

SpectrumDNA Debt Ratio

3.24

It appears most of the SpectrumDNA's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the SpectrumDNA's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of SpectrumDNA, which in turn will lower the firm's financial flexibility.

SpectrumDNA Short Long Term Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how SpectrumDNA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SpectrumDNA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as SpectrumDNA. By using and applying SpectrumDNA Stock analysis, traders can create a robust methodology for identifying SpectrumDNA entry and exit points for their positions.

When running SpectrumDNA's price analysis, check to measure SpectrumDNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectrumDNA is operating at the current time. Most of SpectrumDNA's value examination focuses on studying past and present price action to predict the probability of SpectrumDNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectrumDNA's price. Additionally, you may evaluate how the addition of SpectrumDNA to your portfolios can decrease your overall portfolio volatility.